Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ed Dul"'
Autor:
Yong Jiang, Tia Lewis, Patricia M. McCormick, Michael Schaber, Beth Pietrak, Rachel D. Totoritis, Marc A. Holbert, Lawrence M. Szewczuk, Daniel Fornwald, William G. Bonnette, Geoffrey Quinque, Maggie Grimes, Rosalie E. Matico, Ed Dul, Randy K. Bledsoe, Derrick W. Meinhold, Stephanie Chen
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports
Scientific Reports
Significant resource is spent by drug discovery project teams to generate numerous, yet unique target constructs for the multiple platforms used to drive drug discovery programs including: functional assays, biophysical studies, structural biology, a
Autor:
Thomas D. Sweitzer, Ed Dul, Quinn Lu, Robert S. Ames, Wensheng Xie, Hu Li, Christina S. Pao, Taylor L. Graham
Publikováno v:
ASSAY and Drug Development Technologies. 10:514-524
Nuclear-factor-E2-related transcription factor 2 (Nrf2) regulates a large panel of Phase II genes and plays an important role in cell survival. Nrf2 activation has been shown as preventing cigarette smoke-induced alveolar enlargement in mice. Therefo
Autor:
Ed Dul, Robert B. Kirkpatrick, Sanjay S. Khandekar, Gary K. Smith, Tracey Yi, Gilbert F. Scott, Susan Chen, Lois L. Wrigh, Dennis Lee, Erding Hu
Publikováno v:
Protein & Peptide Letters. 13:369-376
Rho Kinase I (ROCK I) is a serine/threonine kinase that is involved in diverse cellular signaling. To further understand the physiological role of ROCK I and to identify and develop potent and selective inhibitors of ROCK I, we have overexpressed and
Publikováno v:
Genetics. 115:585-590
Starting with the λ p RE -strain λctr1 cy3008, which forms clear plaques, we have isolated two mutant strains, λdya2 ctr1 cy3008 and λdya3 ctr1 cy3008, that form plaques with very slightly turbid centers. The dya2 and dya3 mutations lie in the re